Mahendra A
GLP-1 drugs have also been linked to gastrointestinal issues, the most severe of which include bowel obstruction and stomach paralysis, but these side effects are rare and are currently listed on the drugs labels
Monitoring and titration If you are microdosing GLP-1 medications, it is important to track the side effects carefully, particularly gastrointestinal side effects such as nausea, vomiting, diarrhea, and constipation
revealed a nonsignificant improvement in headache
Additional risks include diabetic retinopathy complications (particularly with semaglutide in patients with pre-existing retinopathy), acute kidney injury (especially with volume depletion from gastrointestinal effects), and rare cases of intestinal obstruction or ileus
Participants were assigned to receive weekly doses of retatrutide at 1 mg, 4 mg, 8 mg, or 12 mg for 48 weeks, or placebo